comparing the effect of aspirin and the combination of aspirin with Osvix after surgery, on surgery outcomes in patients are candidates for Coronary artery bypass grafting

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N157

Enrollment

130

Registered

2021-04-25

Start date

2021-05-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery bypass grafting. Mechanical complication of coronary artery bypass and valve grafts

Interventions

Intervention 1: Intervention group: receive aspirin 80mg (Jalinos company) daily. Intervention 2: Intervention group: is given aspirin 80 mg (Jalinos company) daily and Osvix (Osveh company) daily at

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Both of gender Candidates for Coronary artery bypass grafting

Exclusion criteria

Exclusion criteria: dissatisfaction

Design outcomes

Primary

Measure	Time frame
Incidence of myocardial infarction. Timepoint: 6 months after surgery. Method of measurement: Physical examination.;Received platelets. Timepoint: 72 hours after surgery. Method of measurement: Observation.;Bleeding. Timepoint: To 72 hours after surgery. Method of measurement: Millilitre.;Packcell amount received. Timepoint: To 72 hours after surgery. Method of measurement: Observation.;FFP received. Timepoint: To 72 hours after surgery. Method of measurement: Observation.	—

Measure

Time frame

Incidence of myocardial infarction. Timepoint: 6 months after surgery. Method of measurement: Physical examination.;Received platelets. Timepoint: 72 hours after surgery. Method of measurement: Observation.;Bleeding. Timepoint: To 72 hours after surgery. Method of measurement: Millilitre.;Packcell amount received. Timepoint: To 72 hours after surgery. Method of measurement: Observation.;FFP received. Timepoint: To 72 hours after surgery. Method of measurement: Observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza rostami

Arak University of Medical Sciences

Rostami@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026